Tuesday, January 31, 2023

Heart, Vein Disease Deaths High In 25-To-44-Year-Olds

›
  by Petr Svab via The Epoch Times  (emphasis ours), Diseases of the heart and veins claimed more lives over the past several years among Am...

What Happens When Patients Stop Weight-Loss Medications?

›
  Ania Jastreboff, MD, PhD, a professor at Yale School of Medicine and director of weight management and obesity prevention at Yale Stress C...

'High Rates of Psychiatric Disorders' in Patients With Alopecia Areata

›
  Patients with alopecia areata (AA) had rates of anxiety and depression two to three times higher than the general population, and more tha...

Prothena Alzheimer's Med Hits Safety Goal in Phase 1

›
  Results from a single ascending dose (SAD) study in healthy volunteers demonstrated dose-proportional PRX005 concentrations in plasma with...

Biosynex and Chembio Diagnostics Announce Definitive Acquisition Agreement

›
  Complementary Technologies, Product Portfolios, and Market Opportunities Expected to Represent Significant Growth Drivers Consolidated Man...

Chronic disease biotech Structure Therapeutics sets terms for $125 million IPO

›
  Structure Therapeutics, a Phase 1 biotech developing G-protein-coupled receptors for chronic diseases, announced terms for its IPO on Mond...

Amgen revenue falls slightly as Lilly COVID deal contributes less

›
  Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue ...